Fate Therapeutics Inc FATE:NASDAQ

Last Price$45.03NASDAQ Closing Price as of 4:00PM ET 10/28/20

Today's Change-2.43(5.12%)
Bid (Size)$40.53 (1)
Ask (Size)$48.98 (2)
Day Low / High$44.95 - 46.50
Volume418.7 K
ValuationIndustry Range
Price / Earnings N/A
0.94249.56
Book Value 3.78
 
-53.7885.42
Earnings Per Share -$1.57
 
-61.0630.21
Price To Sales Ratio 153.25
 
0.1431.2K
Price To Book Ratio 6.10
 
N/A120.69
Price To Tangible Book Ratio 6.10
 
0.01129.35
Price/Cash Flow Ratio N/A
2.89313.66
Price/Free Cash Flow Ratio N/A
2.89783.10
ProfileIndustry Range
Market Capitalization 4.2B
 
909.0K133.0B
Float (MRQ)91.46%
 
0.00121.51
Shares Outstanding (MRQ)79.3M
 
16.7 K1.3 B
Short Interest as a % of Float (MRQ)16.31%
 
N/AN/A
Shares Held By Institutions (MRQ)82.2M
 
0.00121.51
MarginsIndustry Range
Sales $13.2M
 
0.006.1B
Gross Margin N/A
-6.7K98.47
Net Profit Margin -881.86%
 
-435.1K1.5K
EBIT Margin -903.76%
 
-417.5K61.67
EBITDA Margin -883.60%
 
-387.5K62.07
Operating Margins -903.76%
 
-254.1K61.67
All fundamentals are Trailing Twelve Months (TTM) unless noted. Preliminary data is based on the company's 8-K statement or press releases. MRQ = Most Recent Quarter
Financial StrengthIndustry Range
Current Ratio (MRQ)8.17
 
0.0066.09
Quick Ratio (MRQ)8.17
 
0.0065.66
Total Debt/Equity Ratio (MRQ)17.09
 
0.002,647.59
Debt/Common Equity Ratio (MRQ)17.09
 
0.002,647.59
EffectivenessIndustry Range
Return on Equity -38.64%
 
-4.0K286.97
Return on Assets -36.37%
 
-5.1K44.83
Asset Turnover 0.04
 
0.002.01
Receivables Turnover N/A
0.004.7K
Inventory Turnover N/A
0.03232.46
Earnings and DividendsIndustry Range
EPS Growth Annual 27.87%
 
N/AN/A
Dividend Yield 5 Year Average 0.00%
 
0.002.85
Current Dividend Yield 0.00%
 
0.47 4.48
Current Payout Ratio N/A
0.0059.75
*FATE does not pay a dividend. The average dividend yield for companies in the Biotechnology industry is 0.78%